Global Kidney Academy - Global Kidney Academy

Global Kidney Academy

Global Kidney Academy

Enhance your nephrology practice with CME and tools focused on kidney medicine.

Popular

Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
IgAN
Reframing IgAN Care: Patient-Centered Strategies to Curb Proteinuria and Preserve Kidney Function
Chee Kay Cheung, MBChB, PhD, FRCP; Jürgen Floege, MD
- Chee Kay Cheung, MBChB, PhD, FRCP
- Jürgen Floege, MD
- Claudia Seikrit, MD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CE
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP; Claudia Seikrit, MD
0.25 credits
- Chee Kay Cheung, MBChB, PhD, FRCP
- Claudia Seikrit, MD
0.25 credits
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Nephrology
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
- Brendon Neuen, MBBS, PhD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CE
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Nephrology
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
- Ellie Kelepouris, MD, FACP, FAHA
CKD-aP or Something Else? Decoding the Diagnosis
CKD-aP or Something Else? Decoding the Diagnosis
MinuteCE®
CKD-aP or Something Else? Decoding the Diagnosis
James Burton, DM, FRCP; Emilio Sanchez, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit

Programs

Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Inside the IgAN Clinic: Shared Decision-Making Into Practice
CME/CE
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
0.25 credits
- Jonathan Barratt, MD, PhD
0.25 credits
The Patient-Clinician Connection in Managing CKD-aP 
The Patient-Clinician Connection in Managing CKD-aP 
MinuteCE®
The Patient-Clinician Connection in Managing CKD-aP 
James Burton, DM, FRCP; Lucio Manenti, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Lucio Manenti, MD, PhD
1.00 program credit
Kappa-Opioid Settings: Real-World Evidence Insights 
Kappa-Opioid Settings: Real-World Evidence Insights 
MinuteCE®
Kappa-Opioid Settings: Real-World Evidence Insights 
Lucio Manenti, MD, PhD; Emilio Sanchez, MD, PhD
1.00 program credit
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 program credit
Elevating CKD-aP Care: New Frontier 
Elevating CKD-aP Care: New Frontier 
MinuteCE®
Elevating CKD-aP Care: New Frontier 
James Burton, DM, FRCP; Lucio Manenti, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Lucio Manenti, MD, PhD
1.00 program credit
CKD-aP Treatment Tool Kit 
CKD-aP Treatment Tool Kit 
MinuteCE®
CKD-aP Treatment Tool Kit 
Leonie Kraft, MD; Emilio Sanchez, MD, PhD
1.00 program credit
- Leonie Kraft, MD
- Emilio Sanchez, MD, PhD
1.00 program credit
Is CKD-aP Hiding in Your Dialysis Center?
Is CKD-aP Hiding in Your Dialysis Center?
MinuteCE®
Is CKD-aP Hiding in Your Dialysis Center?
James Burton, DM, FRCP; Emilio Sanchez, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
MinuteCE®
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
James Burton, DM, FRCP; Patrick Rossignol, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Patrick Rossignol, MD, PhD
1.00 program credit

CME

Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
Nephrology
Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
Kirk Campbell, MD; Jai Radhakrishnan, MD
- Kirk Campbell, MD
- Jai Radhakrishnan, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA; Nihar R. Desai, MD, MPH
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
MinuteCE®
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP; Leonie Kraft, MD
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Leonie Kraft, MD
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 credit 9 episodes
Quantifying CKD-aP: Tools for Better Care 
Quantifying CKD-aP: Tools for Better Care 
MinuteCE®
Quantifying CKD-aP: Tools for Better Care 
James Burton, DM, FRCP; Emilio Sanchez, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Emilio Sanchez, MD, PhD
1.00 program credit
Potassium Binders: Safety Comes First!
Potassium Binders: Safety Comes First!
MinuteCE®
Potassium Binders: Safety Comes First!
Ellie Kelepouris, MD, FACP, FAHA; Javed Butler, MD, MPH, MBA
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Javed Butler, MD, MPH, MBA
1.00 program credit
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
MinuteCE®
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Ellie Kelepouris, MD, FACP, FAHA; Javed Butler, MD, MPH, MBA
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Javed Butler, MD, MPH, MBA
1.00 program credit
The Critical Interplay: CKD, HF, and HyperkaleAmia
The Critical Interplay: CKD, HF, and HyperkaleAmia
MinuteCE®
The Critical Interplay: CKD, HF, and HyperkaleAmia
James Burton, DM, FRCP; Javed Butler, MD
1.00 program credit
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
MinuteCE®
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Ellie Kelepouris, MD, FACP, FAHA; Patrick Rossignol, MD, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit